z-logo
open-access-imgOpen Access
Is There Any Clinically Relevant Cannabinoid-Induced Analgesia?
Author(s) -
Birgit Kraft
Publication year - 2012
Publication title -
pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.51
H-Index - 59
eISSN - 1423-0313
pISSN - 0031-7012
DOI - 10.1159/000337376
Subject(s) - cannabinoid , cannabinoid receptor , analgesic , cannabinoid receptor agonists , medicine , cannabis sativa , endocannabinoid system , synthetic cannabinoids , placebo , pharmacology , chronic pain , clinical trial , anesthesia , receptor , psychiatry , agonist , biology , botany , alternative medicine , pathology
Cannabis sativa is one of the oldest crops cultivated for the production of fibers and for medical and recreational purposes. Since the detection of specific cannabinoid receptors and their physiological ligands, the understanding of the cannabinoid signalling system has increased, leading to a recent resurgence of interest in its medicinal properties. In animal studies, cannabinoids exerted significant analgesic and antihyperalgesic effects, suggesting the usefulness of cannabinoids in pain conditions. However, in human experimental or clinical trials, no convincing reduction of acute pain was observed. In contrast, in chronic pain and (painful) spasticity, an increasing number of randomized, double-blind, placebo-controlled studies have shown some efficacy of cannabinoids. Besides pain, cannabinoids consistently improved mood, sleep and coping. Although cannabinoids are not first-line analgesics, they may be useful adjuvants for some special groups of patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom